Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2009Journal of Lipid ResearchOpen Access

A new method for measurement of total plasma PCSK9: clinical applications

View Full Paper
Ask AI
Bookmark
Share

Authors

GDGeneviève DubucMontreal Clinical Research InstituteMTMichel J. TremblayCentre hospitalier universitaire de QuébecGPGuillaume ParéGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dubuc et al. (2009) studied this question.

synapsesocial.com/papers/69df0f9bd85e58e37b7a1124https://doi.org/10.1194/jlr.m900273-jlr200
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Unravelling the functional significance of PCSK92007 · 84 citations
  2. 2Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/Kexin Type 92008 · 94 citations
  3. 3A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates2009 · 420 citations
  4. 4PCSK9: a convertase that coordinates LDL catabolism2008 · 638 citations
  5. 5The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A2006 · 277 citations